2468-1245

Pediatric Hematology Oncology Journal

Elsevier

Health Score

0 Poor

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 2429 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

High impact2429 DOIs
2

Attach ORCID iDs across 2089 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact2089 DOIs
3

Deposit reference lists for 1992 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

High impact1992 DOIs

DOIs for this ISSN

Showing the top 5 of 2429 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Burden of thalassemia in India: The road map for control (10.1016/j.phoj.2017.10.002)
Abstract ORCID
106.36 133
2 Implementation of risk adapted therapeutic strategy for chil… (10.1016/j.phoj.2018.11.052)
Abstract References ORCID
83.55 12
3 Indian Pediatric Oncology Group (InPOG) – Collaborative rese… (10.1016/j.phoj.2016.04.005)
Abstract ORCID
80.64 40
4 Incidence of childhood leukemia and lymphoma in India (10.1016/j.phoj.2017.12.004)
Abstract ORCID
76.57 33
5 WHO Global Initiative for childhood cancer – India responds (10.1016/j.phoj.2020.06.005)
Abstract ORCID
63.94 18
6 Effect of cold storage on platelets quality stored in a smal… (10.1016/j.phoj.2017.07.001)
Abstract ORCID
62.76 17
7 The burden of thalassemia in Punjab: A roadmap forward (10.1016/j.phoj.2018.01.001)
Abstract ORCID
55.70 12
8 Initial experience of Emicizumab prophylaxis in children wit… (10.1016/j.phoj.2021.03.004)
Abstract ORCID
53.96 11
9 Allogeneic stem cell transplantation for thalassemia major i… (10.1016/j.phoj.2018.02.001)
Abstract ORCID
50.00 9
10 Profile of down syndrome–associated malignancies: Epidemiolo… (10.1016/j.phoj.2021.01.001)
Abstract ORCID
50.00 9
11 Iron overload in steady state, non-chronically transfused ch… (10.1016/j.phoj.2017.08.001)
Abstract ORCID
47.71 8
12 Decreasing cardiac iron overload with Amlodipine and Spiruli… (10.1016/j.phoj.2018.10.001)
Abstract ORCID
47.71 8
13 Factors associated with mortality from gram-negative bacteri… (10.1016/j.phoj.2023.01.005)
Abstract ORCID
47.71 8
14 Pediatric ependymomas: Something old, something new (10.1016/j.phoj.2023.04.002)
Abstract ORCID
47.71 8
15 A structured approach to iron refractory iron deficiency ane… (10.1016/j.phoj.2017.08.003)
Abstract ORCID
45.15 7
16 Novel and innovative approaches for treatment of β-thalassem… (10.1016/j.phoj.2017.11.153)
Abstract ORCID
45.15 7
17 Growth and endocrine issues in children with thalassemia (10.1016/j.phoj.2017.12.005)
Abstract ORCID
45.15 7
18 Long term effects of therapy among childhood cancer survivor… (10.1016/j.phoj.2019.03.002)
Abstract ORCID
45.15 7
19 Plasma level of antioxidants is related to frequency of vaso… (10.1016/j.phoj.2019.03.003)
Abstract ORCID
45.15 7
20 Managing Wilms Tumor: A Single Centre Experience From North… (10.1016/j.phoj.2019.08.154)
Abstract References ORCID
45.15 3
21 Asian Pediatric Hematology and Oncology Group (APHOG) and SI… (10.1016/j.phoj.2020.03.004)
Abstract ORCID
45.15 7
22 Developing an automated dose advice programme to assist adap… (10.1016/j.phoj.2021.04.025)
Abstract References ORCID
45.15 3
23 Response to standard vs low dose emicizumab in inhibitor pos… (10.1016/j.phoj.2022.03.022)
Abstract References ORCID
45.15 3
24 Chemotherapy for osteosarcoma: Adverse effects and remedial… (10.1016/j.phoj.2017.07.002)
Abstract ORCID
42.25 6
25 Cancer epidemiology and the “incidence gap” from non-diagnos… (10.1016/j.phoj.2019.02.001)
Abstract ORCID
42.25 6
26 Comparative therapeutic effect of the L-arginine and sildena… (10.1016/j.phoj.2020.05.002)
Abstract ORCID
42.25 6
27 Wilms tumor in childhood: Single centre retrospective study… (10.1016/j.phoj.2016.07.006)
Abstract ORCID
38.91 5
28 Relapse of Wilms tumor after 20 years: A rare presentation a… (10.1016/j.phoj.2017.02.001)
Abstract ORCID
38.91 5
29 Data collection in the Collaborative Wilms Tumour Africa Pro… (10.1016/j.phoj.2018.09.001)
Abstract ORCID
38.91 5
30 Clinical audit of a Paediatric Emergency Warning Score (PEWS… (10.1016/j.phoj.2020.06.006)
Abstract ORCID
38.91 5
31 Therapeutic drug monitoring informs asparaginase dose schedu… (10.1016/j.phoj.2017.11.132)
Abstract References ORCID
35.78 2
32 Out-of-pocket expenditure incurred by families of children n… (10.1016/j.phoj.2017.11.136)
Abstract References ORCID
35.78 2
33 The indian childhood cancer survivorship study (C2S study):… (10.1016/j.phoj.2017.11.140)
Abstract References ORCID
35.78 2
34 Children’s participation in decisions, discussions, and acti… (10.1016/j.phoj.2017.11.143)
Abstract References ORCID
35.78 2
35 Exploring Barriers To Accessing Care For Childhood Cancers I… (10.1016/j.phoj.2018.11.004)
Abstract References ORCID
35.78 2
36 Twenty-seven year follow-up of Fanconi Anemia from REFAIN (R… (10.1016/j.phoj.2018.11.009)
Abstract References ORCID
35.78 2
37 Plotting Healthcare Journeys And Exploring Time Taken For Ch… (10.1016/j.phoj.2018.11.036)
Abstract References ORCID
35.78 2
38 Paediatric rhabdomyosarcoma: a regional cancer centre experi… (10.1016/j.phoj.2018.11.154)
Abstract References ORCID
35.78 2
39 Fighting The Rising Spectre Of Tough Bugs: A Ten Year Experi… (10.1016/j.phoj.2018.11.178)
Abstract References ORCID
35.78 2
40 Gender bias in health seeking behaviour of families of child… (10.1016/j.phoj.2019.08.031)
Abstract References ORCID
35.78 2
41 Outcome of fanconi anemia after hematopoietic stem cell tran… (10.1016/j.phoj.2019.08.135)
Abstract References ORCID
35.78 2
42 Undernutrition leads to inferior clinical outcomes in childr… (10.1016/j.phoj.2021.04.168)
Abstract References ORCID
35.78 2
43 Cytokine release syndrome with immune reconstitution inflamm… (10.1016/j.phoj.2022.10.072)
Abstract References ORCID
35.78 2
44 Psychological impact of art therapy on children undergoing l… (10.1016/j.phoj.2022.10.083)
Abstract References ORCID
35.78 2
45 Allopurinol adjuvant in acute lymphoblastic leukaemia mainte… (10.1016/j.phoj.2022.10.152)
Abstract References ORCID
35.78 2
46 Teleconsultation: An importatnt tool leading to a paradigm s… (10.1016/j.phoj.2022.10.238)
Abstract References ORCID
35.78 2
47 Romiplostim and immunosuppressive therapy as first line trea… (10.1016/j.phoj.2023.10.164)
Abstract References ORCID
35.78 2
48 Chronic immune thrombocytopenic purpura in children overview… (10.1016/j.phoj.2016.04.002)
Abstract ORCID
34.95 4
49 Prophylaxis and management of antineoplastic drug induced na… (10.1016/j.phoj.2016.09.001)
Abstract ORCID
34.95 4
50 Prevalence of malaria and performance of a rapid diagnostic… (10.1016/j.phoj.2018.06.003)
Abstract ORCID
34.95 4